期刊文献+

血液代用品功能评价参数的研究进展 被引量:1

Research Progress in Estimating Parameters of Blood Substitute Function
原文传递
导出
摘要 全世界范围内血源紧张、病毒污染等问题推动了血液代用品的研究。各种修饰血红蛋白、氟碳乳剂、血红蛋白微囊等技术迅速发展,其中一些已经形成规模化制备工艺。但是,对于血液代用品目前没有完整的评价体系,全面评估血液代用品产品仍较困难。本文根据国内外血液代用品的研究现状和最新进展,重点从血液代用品的评价角度出发,探讨血液代用品的评价参数,围绕血液代用品的理化性质、有效性与安全性、保存条件等方面进行了综述。 The shortage of healthy blood resource and the problem of virus infection have urged the study of blood substitute. The technologies of modified hemoglobin, perfluorocarbons and Hb-vesicles have been developing quickly, and some of which have already been formed into large-scale preparation and production. However, there is no completed evaluation system for the blood substitute at present, and it is still hard to estimate the function of blood substitute completely. This article takes the evaluation of the blood substitute as a key point, discusses the evaluation parameters of blood substitute, and presents the physical and chemical property, the availability and safety as well as the preservation condition of the blood substitute. The data concerned are based on the studies in China and abroad and referred to the latest progress all over the world.
作者 谢家馨 王翔
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2009年第3期657-661,共5页 Journal of Biomedical Engineering
基金 国家自然科学基金资助项目(10572159) 重庆市科委科技计划攻关项目资助(2006ba5010) 高等学校学科创新引智计划项目资助(B06023)
关键词 血液代用品 人工红细胞 评价参数 Blood substitutes Artificial red blood cells Evaluating parameter
  • 相关文献

参考文献19

  • 1王红梅,王保龙,姚萍,苏虹.血液代用品的研究进展[J].临床输血与检验,2005,7(4):314-317. 被引量:7
  • 2CHANG T M. Blood substitutes based on nanoblotechnology [J]. Trends Bioteehnol, 2006, 24(8): 372-377.
  • 3HILL S E. Oxygen therapeutics-current concepts [J]. Can J Anaesth, 2001, 48(4 Suppl) :S32-S40.
  • 4SQUIRESJ E. Artificial blood [J]. Science, 2002, 295 (5557) : 1002-1005.
  • 5路秀玲.修饰血红蛋白作为红细胞代用品的研究进展和挑战[J].生物工程学报,2006,22(1):7-18. 被引量:11
  • 6SHIMORI K, KAWANO Y, KIYOYAMA S, et al. Effective entrapment of protein into polylactide microcapsule by solvent evaporation of W/O/W emulsion[J]. Kagaku Kogaku Ronbunsh, 2000,26(1) :50-55.
  • 7TSUCHIDA E,SAKAI H, HORINOUCHI H, et al. Hemoglobin-vesicles as a transfusion alternative [J]. Artif Cell Blood Substit Immobil Bioteehnol, 2006, 34(6): 581-588.
  • 8COLLETIER J P, CHAIZE B, WINTERHALTER M, et al. Protein encapsulation in liposomes: efficiency depends on interactions between protein and phospholipid bilayer[J]. BMC Biotechnol, 2002, 2:9.
  • 9王雁峰,潘继伦,俞耀庭.红细胞代用品的研究进展[J].生物医学工程学杂志,2004,21(3):490-494. 被引量:4
  • 10MAEVSKY E, IVANITSKY G, BOGDANOVA L, et al. Clinical results of Perftoran application: present and future [J]. Artif Ceils Blood Substit Immobil Biotechnol, 2005, 33 (1) : 37-46.

二级参考文献97

  • 1LU Xiuling, ZHENG Chunyang, XU Yuhong & SU Zhiguo National Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing 100080, China,School of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.Disuccinimidyl suberate cross-linked hemoglobin as a novel red blood cell substitute[J].Science China(Life Sciences),2005,48(1):49-60. 被引量:1
  • 2[1]Naito R,Yokoyama K.An improved perflourodecalin emulsion.In: GA Jamieson,TJ Greenwalt,eds.Blood Substitutes and Plasma Expanders,New York: Alan R Liss Inc,1978;81:87
  • 3[2]Wahr JA,Trouwborst RK,Spence RK,et al.A pilot study of the efficiency of an oxygen earrying emulsion Oxygen(TM.In:patients undergoing surgical blood loss Anesthesiology,1995;80:A397
  • 4[3]Goodin T.Results of a phase I clinical trial of a 40 v/v%emulsion of HM351 (OxygflourTM) in healthy volunteers.2nd Annual IBC Conference on Blood Substitute and Related Products,Washington DC,1994
  • 5[4]Riess,Jean G.Blood substitutes and other potential biomedical applications of fluorinated colloids.Journal of Fluorine Chemistry,2002;114(2):119
  • 6[5]Perutz MF.Myoglobin and hemoglobin: role of distal residues in reactions with haem ligands.Trends Biochem Science,1989;14:42
  • 7[6]Benesch R,Benesch RE,Yung S,et al.Hemoglobin covalently bridged across the polyphosphate binding site.Biochem Phys Res Commun,1975;63:1123
  • 8[7]Gould SA,Moss GS.Clinecal development of human polymerized hemoglobin as a blood substitute.World J Surg,1996;20:1200
  • 9[8]Hughes GS,Yancey EP,Albrecht R,et al.Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.Clin Pharmacol Ther,1995;58:434
  • 10[9]ALi AC.Interference of o-raffinose cross-linked hemoglobin in three methods for serum creatini creatinine.Clin Chem,1997;43:1738

共引文献24

同被引文献27

  • 1Gao W, Sha BY, Zou W, et al. Cationic amylose-encapsulated bovine hemoglobin as a nanosized oxygen carrier, Biomaterials, 2011 (32) :9425-9433.
  • 2Duan L, Yan X, Wang A,et al. Highly loaded hemoglobin spheres as promising artificial oxygen carriers, ACS Nano, 2012, 6 (8): 6897-<i904.
  • 3Gould SA, Moore EE, Hoyt DB, et aI. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.J Am CollSurg, 1998 ,187(2) :113-120. 2.
  • 4Goodnough LT, Shander A, Spence R, et al. Bloodless medicine: clinical care without allogeneic blood transfusion. Transfusion, 2003,43 (5) :668.
  • 5Goodnough LT, Shander A, Brecher ME. Transfusion medicine , looking to the future. Lancet, 2003 ,361 (9352) : 161.
  • 6Robert M. Winslow. Blood Substitutes. Elsevier,2006:424436.
  • 7Vandegriff KD ,Malavalli A, Wooldridge J,et al. MP4, a new nonvasoactive PEG-Hb conjugate. Transfusion ,2003 ,43 (4) :509-516.
  • 8Sakai H, Hamada K, Takeorka S, et al. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol Prog, 1996,12 (1): 119-125.
  • 9Sakai H, Sou K, Horinouchi H,et al. Haemoglobin-vesicles as artificial oxygen earners. } Intern Med ,2007 ,263 (1):4-15.
  • 10Greenbrug AG, Kim HW. Civilian uses of hemoglobin-based oxygen carriers, Artif Organs ,2004 ,28(9) :795-799.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部